Effect of carbon black and silicon dioxide nanoparticle exposure on corona receptor ACE2 and TMPRSS2 expression in the ocular surface.

Publication date: Nov 06, 2024

The Coronavirus disease 2019 (COVID-19) pandemic has led to a global health crisis, including ocular symptoms, primarily targeting the Angiotensin-Converting Enzyme 2 (ACE2) receptor. PM2. 5 air pollution may increase infection risk by altering ACE2 expression. Silicon Dioxide (SiO) and carbon black (CB), major components of PM2. 5 from sands and vehicle emissions, were studied for their effects on ACE2 and Transmembrane Protease Serine 2 (TMPRSS2) expression in corneal and conjunctival cells, and ocular tissues. Human corneal epithelial cells (HCECs) and conjunctival epithelial cells (HCjECs) were exposed to nanoparticles (NPs) for 24 hours, assessing viability via WST-8 assay. TNF-α, IL-6, and IL-1β levels in the medium were measured. An in vivo rat study administered NPs via eye drops, with Rose Bengal staining to evaluate damage. ACE2, TMPRSS2, and Angiotensin II (AngII) protein expressions were quantified by Western blot. ACE2 expression in HCjECs increased with NP exposure, while it decreased in HCECs. CB exposure increased TNF-α, IL-6, and IL-1β levels in HCECs. In vivo, corneal exposure to CB decreased ACE2 expression, whereas conjunctival exposure to SiO increased ACE2 expression. These changes suggest that SiO2 exposure may increase the risk of COVID-19 through the ocular surface, while CB exposure may decrease it.

Open Access PDF

Concepts Keywords
Angiotensin Ace2
Coronavirus Black
Hours Carbon
Nanoparticle Conjunctival
Pandemic Corneal
Dioxide
Exposure
Expression
Hcecs
Il
Increased
Ocular
Receptor
Silicon
Tmprss2

Semantics

Type Source Name
drug DRUGBANK Carbon Black
drug DRUGBANK Silicon dioxide
disease MESH Coronavirus disease 2019
drug DRUGBANK Medical air
disease MESH infection
disease IDO assay
drug DRUGBANK Angiotensin II
disease IDO protein
drug DRUGBANK Serine
disease MESH chest pain
disease MESH sore throat
disease MESH pneumonia
disease MESH acute respiratory distress syndrome
disease MESH multiple organ failure
disease IDO host
drug DRUGBANK Rasagiline
disease MESH fibrosis
disease MESH inflammation
drug DRUGBANK Coenzyme M
disease MESH dry eye disease
drug DRUGBANK Proline

Original Article

(Visited 3 times, 1 visits today)